Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 532

1.

Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.

Saló J, Ginès A, Quer JC, Fernández-Esparrach G, Guevara M, Ginès P, Bataller R, Planas R, Jiménez W, Arroyo V, Rodés J.

J Hepatol. 1996 Dec;25(6):916-23.

PMID:
9007721
2.

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.

Guevara M, Ginès P, Fernández-Esparrach G, Sort P, Salmerón JM, Jiménez W, Arroyo V, Rodés J.

Hepatology. 1998 Jan;27(1):35-41.

PMID:
9425914
3.

Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.

Angeli P, Volpin R, Piovan D, Bortoluzzi A, Craighero R, Bottaro S, Finucci GF, Casiglia E, Sticca A, De Toni R, Pavan L, Gatta A.

Hepatology. 1998 Oct;28(4):937-43.

PMID:
9755229
4.

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine.

Gülberg V, Bilzer M, Gerbes AL.

Hepatology. 1999 Oct;30(4):870-5.

PMID:
10498636
5.
6.

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.

Angeli P, Volpin R, Gerunda G, Craighero R, Roner P, Merenda R, Amodio P, Sticca A, Caregaro L, Maffei-Faccioli A, Gatta A.

Hepatology. 1999 Jun;29(6):1690-7.

PMID:
10347109
7.

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.

Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W, Salmerón JM, Bataller R, Mas A, Navasa M, Arroyo V, Rodés J.

J Hepatol. 2000 Jul;33(1):43-8.

PMID:
10905585
8.

[Successful conservative therapy of hepatorenal syndrome with vasopressin-1-receptor antagonist ornipressin].

Gülberg V, Luppa P, Pauletzki J, Paumgartner G, Gerbes AL.

Z Gastroenterol. 1998 Dec;36(12):1053-8. German.

PMID:
10025057
9.

Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome.

Hadengue A, Gadano A, Moreau R, Giostra E, Durand F, Valla D, Erlinger S, Lebrec D.

J Hepatol. 1998 Oct;29(4):565-70.

PMID:
9824265
10.

The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.

Kalambokis G, Economou M, Fotopoulos A, Al Bokharhii J, Pappas C, Katsaraki A, Tsianos EV.

Am J Gastroenterol. 2005 Apr;100(4):879-85.

PMID:
15784036
11.

Prolonged infusion of ornithine plus dopamine in the treatment of the hepatorenal syndrome: a breakthrough?

Conn HO.

Am J Gastroenterol. 2000 Dec;95(12):3645-6. No abstract available.

PMID:
11151911
12.

Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man.

Richer M, Robert S, Lebel M.

Crit Care Med. 1996 Jul;24(7):1150-6.

PMID:
8674327
13.

Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.

Werner D, Trägner P, Wawer A, Porst H, Daniel WG, Gross P.

Nephrol Dial Transplant. 2005 May;20(5):920-6. Epub 2005 Mar 23.

PMID:
15788437
14.
15.
16.

An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.

Sharma P, Kumar A, Shrama BC, Sarin SK.

Am J Gastroenterol. 2008 Jul;103(7):1689-97. doi: 10.1111/j.1572-0241.2008.01828.x. Epub 2008 Jun 28.

PMID:
18557715
17.
18.

Terlipressin and gelafundin: safe therapy of hepatorenal syndrome.

Saner F, Kavuk I, Lang H, Biglarnia R, Frühauf NR, Schäfers RF, Malagó M, Broelsch CE.

Eur J Med Res. 2004 Feb 27;9(2):78-82.

PMID:
15090293
19.

The renal and neurohumoral effects of the addition of low-dose dopamine in septic critically ill patients.

Girbes AR, Patten MT, McCloskey BV, Groeneveld AB, Hoogenberg K.

Intensive Care Med. 2000 Nov;26(11):1685-9.

PMID:
11193277
20.

[Successful therapy of hepatorenal syndrome with norepinephrine].

Pehl C, Schepp W.

Z Gastroenterol. 2000 Dec;38(12):945-50. German.

PMID:
11194884

Supplemental Content

Support Center